Liver Disease Treatment Market Innovations

PORTLAND, OREGON, UNITED STATES, March 13, 2024 /EINPresswire.com/ -- According to recent reports, the global liver disease treatment industry reached $20.67 billion in 2020 and is anticipated to achieve $36.45 billion by 2030, with a compound annual growth rate (CAGR) of 5.7% from 2021 to 2030.

Key Highlights:

The antiviral drugs segment dominated the market.
The cancer segment is expected to exhibit the highest CAGR through 2030.
North America accounted for the largest market share.
Factors Driving Market Growth:

Rising Prevalence of Liver Diseases:

Increased incidences of hepatitis B and C, non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), and hepatocellular carcinoma (HCC) are propelling market growth.
Lifestyle changes such as unhealthy diets, excessive alcohol consumption, and sedentary behavior contribute to this trend.
Obesity and type 2 diabetes, major risk factors for NAFLD, are becoming more prevalent.
Limited access to clean water and sanitation facilities aids in the spread of hepatitis viruses.

Technological Advancements:

Continuous improvements in diagnostic tools and treatment methods are fostering the adoption of more effective therapies.
Advancements include non-invasive diagnostic tests for early disease detection, enhanced antiviral therapies for hepatitis B and C, and novel drugs for NAFLD and HCC.
Surgical techniques for liver transplantation have also seen significant advancements.

Market Segmentation:

Treatment Types: Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy.
Disease Types: Hepatitis, Autoimmune Diseases, NAFLD, Cancer, Genetic Disorders, Others.
Regions: North America, Europe, Asia-Pacific, LAMEA.

COVID-19 Impact:

The pandemic moderately impacted the liver disease treatment market due to reduced demand for relevant drugs, limited medical access, and healthcare staff shortages.

However, research efforts, including clinical trials for liver disease treatment, increased amidst the pandemic.

Regional Growth Dynamics:

North America dominated the market in 2020, driven by a growing elderly population, adoption of advanced technologies, robust R&D infrastructure, and improved treatment options.

The Asia-Pacific region is projected to witness the highest CAGR during the forecast period, fueled by increasing liver disease cases, rising public-private investments, and government support for pharmaceutical and biotechnology R&D.

Buy this Premium Research Report :

https://www.alliedmarketresearch.com/purchase-enquiry/388

Major Market Players:

AbbVie Inc.
Astellas Pharma Inc.
Abbott Laboratories
Eli Lilly and Company
Bristol Myers Squibb
Emergent BioSolutions (Cangene bioPharma)
F. Hoffman-LA Roche
Merck & Co., Inc. (Merck Sharp & Dohme Corp.)
Gilead Sciences, Inc.
Viatris Inc.

For further insights and customization: https://www.alliedmarketresearch.com/request-for-customization/388

Trending Reports in Healthcare Industry (Book Now with Discount):

Intravenous Immunoglobulin (IVIG) Market – Global Opportunity Analysis and Industry Forecast, 2020–2028

COPD and Asthma Devices Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+1 5038946022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.